Connect with us

Business

US FDA grants emergency use authorization to Regeneron COVID-19 antibody given to Trump – Fox Business

The company said it expects to have does of REGEN-COV2 treatment ready for about 80,000 patients by the end of this month

Published

on

post featured image
ADVERTISEMENT

The U.S. Food and Drug Administration on Saturday issued emergency use authorization for Regeneron Pharmaceuticals Inc’s COVID-19 antibody therapy, an experimental treatment given to U.S. President Donald Trump that he said helped cure him of the disease.
The FDA said the monoclonal antibodies, casirivimab and imdevimab, should be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients with positive results of direct SARS-CoV-2 viral testing and who…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

post featured image
GM to recall nearly 6 million vehicles in U.S. to replace Takata air bags – CBS News
post featured image
If Wall Street’s S&P 500 forecasts for 2021 are wrong, these stocks will prevail, says strategist – MarketWatch
post featured image
I’m 65, have $500,000 in cash, no ‘impressive’ work resume and am terrified of investing — can I retire? – MarketWatch